Cargando…

Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk

Detalles Bibliográficos
Autores principales: Zheutlin, Alexander R., Zhang, Mingyuan, Conroy, Molly B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804006/
https://www.ncbi.nlm.nih.gov/pubmed/36593972
http://dx.doi.org/10.1016/j.ajpc.2022.100450
_version_ 1784862006678913024
author Zheutlin, Alexander R.
Zhang, Mingyuan
Conroy, Molly B.
author_facet Zheutlin, Alexander R.
Zhang, Mingyuan
Conroy, Molly B.
author_sort Zheutlin, Alexander R.
collection PubMed
description
format Online
Article
Text
id pubmed-9804006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98040062023-01-01 Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk Zheutlin, Alexander R. Zhang, Mingyuan Conroy, Molly B. Am J Prev Cardiol Original Research Contribution Elsevier 2022-12-18 /pmc/articles/PMC9804006/ /pubmed/36593972 http://dx.doi.org/10.1016/j.ajpc.2022.100450 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Contribution
Zheutlin, Alexander R.
Zhang, Mingyuan
Conroy, Molly B.
Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title_full Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title_fullStr Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title_full_unstemmed Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title_short Clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
title_sort clinical encounter length and initiation of statin therapy for primary prevention among adults with elevated atherosclerotic cardiovascular disease risk
topic Original Research Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804006/
https://www.ncbi.nlm.nih.gov/pubmed/36593972
http://dx.doi.org/10.1016/j.ajpc.2022.100450
work_keys_str_mv AT zheutlinalexanderr clinicalencounterlengthandinitiationofstatintherapyforprimarypreventionamongadultswithelevatedatheroscleroticcardiovasculardiseaserisk
AT zhangmingyuan clinicalencounterlengthandinitiationofstatintherapyforprimarypreventionamongadultswithelevatedatheroscleroticcardiovasculardiseaserisk
AT conroymollyb clinicalencounterlengthandinitiationofstatintherapyforprimarypreventionamongadultswithelevatedatheroscleroticcardiovasculardiseaserisk